Photodynamic Therapy in Non-Gastrointestinal Thoracic Malignancies
Biniam Kidane1,2, Dhruvin Hirpara3, Kazuhiro Yasufuku4,5
1Division of Thoracic Surgery, University of Toronto, Toronto, ON M5G 2C4, Canada. b.kidane@mail.utoronto.ca.
Abstract:
Photodynamic therapy has a role in the management of early and late thoracic malignancies. It can be used to facilitate minimally-invasive treatment of early endobronchial tumours and also to palliate obstructive and bleeding effects of advanced endobronchial tumours. Photodynamic therapy has been used as a means of downsizing tumours to allow for resection, as well as reducing the extent of resection necessary. It has also been used successfully for minimally-invasive management of local recurrences, which is especially valuable for patients who are not eligible for radiation therapy. Photodynamic therapy has also shown promising results in mesothelioma and pleural-based metastatic disease. As new generation photosensitizers are being developed and tested and methodological issues continue to be addressed, the role of photodynamic therapy in thoracic malignancies continues to evolve.


